I disagree with the opinions expressed about halting pursuit of our NANOSE Technology. Breathtec remains in hot pursuit of multiple revenue streams including a Pharmaceutical Deal. All our eggs are not in one basket. That's smart business IMO. No one here knows which revenue stream will make it across the finish line first. We have global experts in their field and expert consultants who mapped out some of our paths to marketing approval. Why narrow our path down to a one lane bottleneck versus a multiple lane Autobahn? The drum beat regarding a PP remains another opinion. Even still - were sitting at 55 mill shares outstanding. That's not a lot of shares. I personally believe Breathtec's value will be a minimum of 10 times the value of its sister company when all is said and done. How many shares are currently outstanding over there? Do the math. Breathtec is 15 months into existence with shareholders. Cannabix is 35 months into existence with shareholders. It seems to me that some Cannabix shareholders are unfairly dumping their frustration with Cannabix management and delays onto Breathtec.
News 
Market Data 
Discover 
